Diet-Induced Microbiome's Impact on Heart Failure: A Double-Edged Sword.
Alexandre RodriguesAlexandre GonçalvesJuliana MoraisRicardo AraujoInês Falcão PiresPublished in: Nutrients (2023)
Heart failure (HF) is a debilitating disease with a significant clinical and economic impact worldwide. Multiple factors seem to increase the risk of developing HF, such as hypertension, obesity and diabetes. Since chronic inflammation plays a significant role in HF pathophysiology and gut dysbiosis is associated with low-grade chronic inflammation, the risk of cardiovascular diseases is likely modulated by the gut microbiome (GM). Considerable progress has been made in HF management. However, there is a need to find new strategies to reduce mortality and increase the quality of life, mainly of HFpEF patients, since its prevalence continues to rise. Recent studies validate that lifestyle changes, such as diet modulation, represent a potential therapeutic approach to improve several cardiometabolic diseases, although their effects on the GM and its indirect cardiac impact still warrant further research. Hence, in this paper, we aim to clarify the link between HF and the human microbiome.
Keyphrases
- heart failure
- acute heart failure
- low grade
- cardiovascular disease
- weight loss
- type diabetes
- end stage renal disease
- left ventricular
- metabolic syndrome
- oxidative stress
- blood pressure
- endothelial cells
- physical activity
- high grade
- ejection fraction
- insulin resistance
- chronic kidney disease
- atrial fibrillation
- peritoneal dialysis
- cardiovascular events
- coronary artery disease
- adipose tissue
- glycemic control
- weight gain
- body mass index
- drug induced